| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CYTK | Common Stock | Sale | -$257K | -7.85K | -5.15% | $32.78 | 145K | Sep 1, 2021 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2021. |
| F2 | Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan. |